Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
4.080
+0.630 (18.26%)
Aug 4, 2026, 11:37 AM EDT - Market open
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $4.76 million as of August 4, 2026. Its market cap has decreased by -65.02% in one year.
Market Cap
4.76M
Enterprise Value
-4.76M
1-Year Change
-65.02%
Ranking
Category
Stock Price
$4.08
ChartMarket Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $4.76M, a decrease of -97.59%. That is a compound annual growth rate of -50.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 3.83M | -59.38% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 4.55M |
| Silo Pharma | 4.54M |
| TransCode Therapeutics | 4.33M |
| Mustang Bio | 4.32M |
| PMGC Holdings | 4.19M |
| Galmed Pharmaceuticals | 4.10M |
| SciSparc | 4.08M |
| Jupiter Neurosciences | 3.91M |